212 related articles for article (PubMed ID: 20814306)
1. Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity.
Prayle A; Smyth AR
Curr Opin Pulm Med; 2010 Nov; 16(6):604-10. PubMed ID: 20814306
[TBL] [Abstract][Full Text] [Related]
2. Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis.
Saad A; Young MR; Studtmann AE; Autry EB; Schadler A; Beckman EJ; Gardner BM; Wurth MA; Kuhn RJ
Pediatr Pulmonol; 2020 Dec; 55(12):3384-3390. PubMed ID: 32910553
[TBL] [Abstract][Full Text] [Related]
3. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.
Young DC; Zobell JT; Stockmann C; Waters CD; Ampofo K; Sherwin CM; Spigarelli MG
Pediatr Pulmonol; 2013 Nov; 48(11):1047-61. PubMed ID: 24000183
[TBL] [Abstract][Full Text] [Related]
4. Urinary Biomarkers of Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin.
McWilliam SJ; Antoine DJ; Jorgensen AL; Smyth RL; Pirmohamed M
Sci Rep; 2018 Mar; 8(1):5094. PubMed ID: 29572451
[TBL] [Abstract][Full Text] [Related]
5. Unwarranted use of intravenous aminoglycosides at UK paediatric cystic fibrosis centres.
Ditchfield N; Carroll WD; Gilchrist FJ
J Cyst Fibros; 2019 Nov; 18(6):e58-e59. PubMed ID: 31522925
[No Abstract] [Full Text] [Related]
6. Exploring the Relationship between FEV
Hoff BM; Scheetz MH; Jain M; Cullina JF; Rhodes NJ
Pharmacotherapy; 2020 Jun; 40(6):584-591. PubMed ID: 32259317
[TBL] [Abstract][Full Text] [Related]
7. Minimizing the toxicity of aminoglycosides in cystic fibrosis.
Smyth AR
J R Soc Med; 2010 Jul; 103 Suppl 1(Suppl 1):S3-5. PubMed ID: 20573667
[No Abstract] [Full Text] [Related]
8. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
Prescott WA
Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
[TBL] [Abstract][Full Text] [Related]
9. Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin.
Garinis A; Gleser M; Johns A; Larsen E; Vachhani J
J Cyst Fibros; 2021 Mar; 20(2):278-283. PubMed ID: 32713806
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis.
Ochs MA; Dillman NO; Caverly LJ; Chaffee VD
Pediatr Pulmonol; 2021 Dec; 56(12):3634-3643. PubMed ID: 33983680
[TBL] [Abstract][Full Text] [Related]
11. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
Edson RS; Keys TF
Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
[TBL] [Abstract][Full Text] [Related]
12. Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES).
Al-Aloul M; Miller H; Stockton P; Ledson MJ; Walshaw MJ
J Cyst Fibros; 2005 Sep; 4(3):197-201. PubMed ID: 15967735
[TBL] [Abstract][Full Text] [Related]
13. Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy.
Mulheran M; Degg C; Burr S; Morgan DW; Stableforth DE
Antimicrob Agents Chemother; 2001 Sep; 45(9):2502-9. PubMed ID: 11502521
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis, aminoglycoside treatment and acute renal failure: the not so gentle micin.
Bockenhauer D; Hug MJ; Kleta R
Pediatr Nephrol; 2009 May; 24(5):925-8. PubMed ID: 19005685
[TBL] [Abstract][Full Text] [Related]
15. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
Prescott WA; Nagel JL
Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
[TBL] [Abstract][Full Text] [Related]
16. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Bhatt J; Jahnke N; Smyth AR
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison.
Prayle AP; Jain K; Touw DJ; Koch BC; Knox AJ; Watson A; Smyth AR
J Cyst Fibros; 2016 Jul; 15(4):510-7. PubMed ID: 26282839
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis.
Florescu MC; Lyden E; Murphy PJ; Florescu DF; Fillaus J
Hemodial Int; 2012 Jul; 16(3):414-9. PubMed ID: 22469183
[TBL] [Abstract][Full Text] [Related]
19. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2010 Jan; (1):CD002009. PubMed ID: 20091528
[TBL] [Abstract][Full Text] [Related]
20. Daily serum creatinine monitoring promotes earlier detection of acute kidney injury in children and adolescents with cystic fibrosis.
Downes KJ; Rao MB; Kahill L; Nguyen H; Clancy JP; Goldstein SL
J Cyst Fibros; 2014 Jul; 13(4):435-41. PubMed ID: 24718099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
